ERBB2 and breast cancer: The prognostic significance of FENDRR was also demonstrated in breast cancer, where FENDRR was downregulated and correlated with shorter overall and progression-free survival of patients, and associated with increasing PR, HER-2, and lymphatic metastasis.24